DE69316978D1 - Pharmazeutische zusammensetzung mit ortspezifischen verabreichung - Google Patents

Pharmazeutische zusammensetzung mit ortspezifischen verabreichung

Info

Publication number
DE69316978D1
DE69316978D1 DE69316978T DE69316978T DE69316978D1 DE 69316978 D1 DE69316978 D1 DE 69316978D1 DE 69316978 T DE69316978 T DE 69316978T DE 69316978 T DE69316978 T DE 69316978T DE 69316978 D1 DE69316978 D1 DE 69316978D1
Authority
DE
Germany
Prior art keywords
pct
spacer
sec
alpha
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69316978T
Other languages
English (en)
Inventor
Erik Franssen
Frits Moolenaar
Dirk Meijer
Zeeuw Dick De
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rijksuniversiteit Groningen
Original Assignee
Rijksuniversiteit Groningen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rijksuniversiteit Groningen filed Critical Rijksuniversiteit Groningen
Application granted granted Critical
Publication of DE69316978D1 publication Critical patent/DE69316978D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
    • Y10S530/812—Peptides or proteins is immobilized on, or in, an organic carrier
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
    • Y10S530/812—Peptides or proteins is immobilized on, or in, an organic carrier
    • Y10S530/815—Carrier is a synthetic polymer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
DE69316978T 1992-03-13 1993-03-15 Pharmazeutische zusammensetzung mit ortspezifischen verabreichung Expired - Lifetime DE69316978D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL9200481A NL9200481A (nl) 1992-03-13 1992-03-13 Farmaceutisch preparaat met plaatsgerichte afgifte.
PCT/NL1993/000061 WO1993017713A1 (en) 1992-03-13 1993-03-15 Pharmaceutical composition having site-specific delivery

Publications (1)

Publication Number Publication Date
DE69316978D1 true DE69316978D1 (de) 1998-03-19

Family

ID=19860559

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69316978T Expired - Lifetime DE69316978D1 (de) 1992-03-13 1993-03-15 Pharmazeutische zusammensetzung mit ortspezifischen verabreichung

Country Status (10)

Country Link
US (1) US5753611A (de)
EP (1) EP0630263B1 (de)
JP (1) JPH07507272A (de)
AT (1) ATE163133T1 (de)
AU (1) AU666541B2 (de)
CA (1) CA2131990A1 (de)
DE (1) DE69316978D1 (de)
NL (1) NL9200481A (de)
NZ (1) NZ251449A (de)
WO (1) WO1993017713A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5993805A (en) * 1991-04-10 1999-11-30 Quadrant Healthcare (Uk) Limited Spray-dried microparticles and their use as therapeutic vehicles
US5607691A (en) * 1992-06-12 1997-03-04 Affymax Technologies N.V. Compositions and methods for enhanced drug delivery
US5955108A (en) * 1994-12-16 1999-09-21 Quadrant Healthcare (Uk) Limited Cross-linked microparticles and their use as therapeutic vehicles
CN1201447A (zh) * 1995-10-06 1998-12-09 沃泰克斯药物股份有限公司 乳酸的丁酸酯前药
DE19724670A1 (de) * 1997-06-11 1998-12-24 Max Planck Gesellschaft Inkorporation von pharmakologisch wirksamen Aminosäureanaloga in Proteine
US7354584B2 (en) 2003-04-11 2008-04-08 Medimmune, Inc. Recombinant IL-9 antibodies
DE102004057196A1 (de) * 2004-11-26 2006-06-01 Rösner Research GmbH & Co.KG Verfahren zur Herstellung von Albumin-Konjugaten mit Nicht-steroidalen Antirheumatika (NSAR)
US7960336B2 (en) 2007-08-03 2011-06-14 Pharmain Corporation Composition for long-acting peptide analogs
US8563527B2 (en) * 2007-08-20 2013-10-22 Pharmain Corporation Oligonucleotide core carrier compositions for delivery of nucleic acid-containing therapeutic agents, methods of making and using the same
EP2274007B1 (de) 2008-03-10 2016-12-14 Cornell University Modulation der durchlässigkeit der blut-hirn-schranke

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8900911A (nl) * 1989-04-12 1990-11-01 Duphar Int Res Drug-targeting naar de nier.

Also Published As

Publication number Publication date
EP0630263A1 (de) 1994-12-28
EP0630263B1 (de) 1998-02-11
NZ251449A (en) 1996-07-26
NL9200481A (nl) 1993-10-01
AU3907493A (en) 1993-10-05
CA2131990A1 (en) 1993-09-16
WO1993017713A1 (en) 1993-09-16
AU666541B2 (en) 1996-02-15
JPH07507272A (ja) 1995-08-10
US5753611A (en) 1998-05-19
ATE163133T1 (de) 1998-02-15

Similar Documents

Publication Publication Date Title
ES2569949T3 (es) Formulaciones farmacéuticas que comprenden un péptido complejado con una dicetopiperazina
NO934573L (no) Farmasoeytiske formuleringer av oste-orgeniske proteiner
DE69428040D1 (de) Orale darreichungsform
DE69429729D1 (de) Orales verabreichungssystem von desferrioxamin
SE8803321D0 (sv) Fordrojd och styrd frigoring av vattenolosliga polypeptider
DE69316978D1 (de) Pharmazeutische zusammensetzung mit ortspezifischen verabreichung
DE69417868T2 (de) Peptidderivate von alpha-msh und deren anwendung
KR890006252A (ko) 분말형 폴리펩타이드의 비강내 투여용 조성물 및 투여방법
KR950703999A (ko) 변성된 인슐린-유사 성장인자(modified insulin-like growth factors)
AU5431390A (en) Novel arylpyridazines, their manufacture, use and medicaments containing them
BR9406363A (pt) Composiçao farmacêutica processo para a preparaçao da mesma uso da mesma e processo para o tratamento de doenças relacionadas com o ácido gástrico
DE69228704T2 (de) Stabilisierte pharmazeutische formulierung, die wachstumshormon und asparagin enthält
JP3829991B2 (ja) Ｈｇｈ含有医薬組成物
ATE173923T1 (de) Oralanzuwendende flüssige arzneizubereitung enthaltend 2-(4-isobutylphenyl)propionsäure
JPS6442433A (en) Fine particle containing biodegradable polymer for controlling release of antimalarial effective component, medicinal composition and manufacture
DE69627691D1 (de) Aus thymischen hormonen abstammende peptid konjugierte, deren verwendung als medikamente und aus deren enthaltende zusammensetzungen
ATE104863T1 (de) Pharmazeutische formulierung von plasminogenaktivatorproteinen.
DK1014948T3 (da) Lyofiliseret farmaceutisk præparat som er beregnet til at efterligne et lægemiddel på basis af proteiner eller polypeptider
DE59811768D1 (de) Pharmazeutische kombinationspräparate enthaltend erythropoietin und modifizierte hämoglobine
PT785795E (pt) Composicao farmaceutica
ATE205829T1 (de) Fibrinogen receptor antagonisten mit substituierten b-aminosäurenestern und diese enthaltende pharmazeutische präparate
AU9221898A (en) Pharmaceutical coating composition and method of use
DE3770658D1 (de) Injizierbare arzneiformulierungen von substanzen mit allgemeiner anaesthetischer wirkung.
DE3879489D1 (de) Pharmazeutische kompositionen zum behandeln von adrenoleukodystrophie.
CA1107647A (en) Stable secretin composition, process for its preparation and its use

Legal Events

Date Code Title Description
8332 No legal effect for de